Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by sollmgon Jan 16, 2023 6:35pm
375 Views
Post# 35226728

Ryplazim

RyplazimNice to see it made the market

May be an image of cosmetics and text that says 'NuFACTOR SHA7 aore mg/vial dnlan 6RRma/vial B plasmino 8263319111 68.8 mg/vial MA 68.8 mg/vial plasminogen, human-tvmh Ryplazim plasminogen, human-tvmh Ryplazim For Intravenous Use Only Sterile, Preservative-Free For Intravenous Use Only Sterile, Preservative-Free Single-Dose Vial Discard Unused Portion Single-Dose Vial Discard Unused Portion 2065 Rx Only'

https://www.ryplazim.com/
<< Previous
Bullboard Posts
Next >>